MD250117P30000
- 0.00
- 0.000.00%
Pediatrix Medical Newsroom
Pediatrix Medical Initiated at Outperform by Macquarie
Pediatrix Medical Group Analyst Ratings
Macquarie Upgrades Pediatrix Medical(MD.US) to Buy Rating, Cuts Target Price to $18
Whit Mayo Maintains Hold Rating on Pediatrix Medical Group Amid Mixed Growth Signals and Policy Concerns
Mizuho Securities Maintains Pediatrix Medical(MD.US) With Hold Rating, Announces Target Price $15
Pediatrix Medical Price Target Raised to $15.00/Share From $13.00 by Mizuho
Pediatrix Medical Is Maintained at Neutral by Mizuho
Pediatrix Medical Group Analyst Ratings
Jefferies Maintains Pediatrix Medical(MD.US) With Buy Rating, Raises Target Price to $18
Jefferies Reaffirms Their Buy Rating on Pediatrix Medical Group (MD)
Cautious Hold Rating for Pediatrix Medical Group Amid Uncertain Long-Term Growth Prospects
Pediatrix Medical Is Maintained at Hold by Deutsche Bank
Truist Financial Maintains Pediatrix Medical(MD.US) With Hold Rating, Raises Target Price to $16
Mizuho Securities Maintains Pediatrix Medical(MD.US) With Hold Rating
Pediatrix Medical Group Analyst Ratings
Truist Financial Maintains Pediatrix Medical(MD.US) With Hold Rating, Raises Target Price to $13
Jefferies Initiates Pediatrix Medical(MD.US) With Buy Rating, Announces Target Price $14
Buy Rating for Pediatrix Medical Group: Undervalued Stock With Strong Growth and Free Cash Flow Potential
Pediatrix Medical Upgraded to Buy From Hold at Jefferies
Pediatrix Medical Price Target Raised to $10.00/Share From $8.00 by Truist Securities